Experience of Use of 177Lu-PSMA in Brazil

被引：0
|
作者：
Viana, A. [1 ]
Nabinger, P. [1 ]
Madke, R. [1 ]
机构：
[1] Grp RPH, Porto Alegre, Brazil
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPS-224
引用
收藏
页码：S400 / S400
页数：1
相关论文
共 50 条
  • [21] Harmonisation of Serial 177Lu-PSMA SPECT/CT Images in Patients with Metastatic Castrate-Resistant Prostate Cancer Treated with 177Lu-PSMA-617: A Prospective Multicentre 177Lu-PSMA SPECT/CT harmonisation (ENZA-p)
    Ayati, N.
    Hioki, T.
    van Oorschodt, J. C. J.
    McGill, G.
    Marquis, H.
    Francis, R.
    Bailey, D.
    Eslick, E.
    Sandhu, S.
    Davis, I. D.
    Stockler, M.
    Subramaniam, S.
    Crumbaker, M.
    Subhash, V.
    Sharma, S.
    Ayers, M.
    Jackson, P.
    Emmett, L.
    Willowson, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S280 - S281
  • [22] Comparison of 68Ga-PSMA and 177Lu-PSMA Total Metabolic Tumor Volume (TMTV) variations for monitoring metastatic castration-resistant prostate cancer in 177Lu-PSMA therapy.
    Boursier, C.
    Zaragori, T.
    Kunsch, J.
    Olivier, P.
    Claudin, M.
    Marie, P.
    Bros, M.
    Bordonne, M.
    Verger, A.
    Karcher, G.
    Imbert, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S361 - S362
  • [23] Radiation levels outside a patient undergoing 177Lu-PSMA radioligand therapy
    Li, Huan
    Liu, Haikuan
    Zhang, Weiyuan
    Lin, Xin
    Li, Zhiling
    Zhuo, Weihai
    JOURNAL OF RADIOLOGICAL PROTECTION, 2024, 44 (02)
  • [24] 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    Sanli, Yasemin
    Simsek, Duygu Has
    Sanli, Oner
    Subramaniam, Rathan M.
    Kendi, Ayse Tuba
    BIOMEDICINES, 2021, 9 (04)
  • [25] Patient dosimetry of 177Lu-PSMA I&T in metastatic prostate cancer treatment: the experience in Thailand
    Kotchakorn Chatachot
    Shuichi Shiratori
    Tawatchai Chaiwatanarat
    Kitiwat Khamwan
    Annals of Nuclear Medicine, 2021, 35 : 1193 - 1202
  • [26] Patient dosimetry of 177Lu-PSMA I&T in metastatic prostate cancer treatment: the experience in Thailand
    Chatachot, Kotchakorn
    Shiratori, Shuichi
    Chaiwatanarat, Tawatchai
    Khamwan, Kitiwat
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (11) : 1193 - 1202
  • [27] 177Lu-PSMA therapy. Current evidence for use in the treatment of patients with metastatic prostate cancer
    Boegemann, M.
    Schrader, A. J.
    Rahbar, K.
    UROLOGE, 2017, 56 (11): : 1440 - 1444
  • [28] Dosimetric evaluation of the lacrimal glands in patients undergoing therapy with 177Lu-PSMA
    Happel, C.
    Voeller, L.
    Kranert, W. T.
    Groener, D.
    Bockisch, B.
    Ngoc, C. Nguyen
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S102 - S103
  • [29] 177Lu-PSMA for advanced prostate cancer: are we ready to play big?
    Charisma Hehakaya
    Ellen H. M. Moors
    Helena M. Verkooijen
    Diederick E. Grobbee
    Frederik A. Verburg
    Marnix G. E. H. Lam
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2325 - 2328
  • [30] 177Lu-PSMA Therapy for Metastatic Testicular Mixed Germ Cell Tumor
    Has Simsek, Duygu
    Civan, Caner
    Ekenel, Meltem
    Kuyumcu, Serkan
    Sanli, Yasemin
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (05) : 415 - 418
12345